according to the australian government s pharmaceutical benefits scheme website based on data provided to the australian department of health and ageing by the manufacturer perindopril arginine and perindopril erbumine are therapeutically equivalent and may be interchanged without differences in clinical effect however the dose prescribed to achieve the same effect differs due to different molecular weights for the two forms a prodrug perindopril is hydrolyzed to its active metabolite perindoprilat in the liver it was patented in 1980 and approved for medical use in 1988 perindopril shares the indications of ace inhibitors as a class including essential hypertension stable coronary artery disease reduction of risk of cardiac events in patients with a history of myocardial infarction and or revascularization and treatment of symptomatic heart disease or heart failure in addition the perindopril protection against recurrent stroke study progress found that perindopril reduces the risk of stroke in both hypertensive and normotensive individuals with a history of stroke or transient ischemic attack the anglo scandinavian cardiac outcomes trial showed the benefits of taking the two drugs perindopril and amlodipine together about 9000 british patients aged 40 to 79 were involved in the five year trial half were given the new